Pediatrix Medical : 2026 – Quarterly Adjusted EBITDA

Published: 2026-05-05 06:29:09 ET MD

Published on 05/05/2026 at 06:29 am EDT

Net income

$

29,572

Interest expense

8,265

Income tax provision

9,272

Depreciation and amortization expense

6,119

4,922

$ 58,150

Transformational and restructuring related expenses

Adjusted EBITDA

PEDIATRIX MEDICAL GROUP, INC.

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA

(in thousands) (Unaudited)

Three Months Ended March 31,

2026

Disclaimer

Pediatrix Medical Group Inc. published this content on May 05, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 05, 2026 at 10:28 UTC.